Purpose of this Study
The Endometrial Cancer Molecularly Targeted Therapy Consortium is a multi-institutional alliance that is developing a cancer data and tissue repository. The information in this repository will be used to better understand tumor alterations and cancer biomarkers that can help us develop new therapies and potentially improve survival outcomes for women with endometrial cancer.
Who Can Participate?
Eligibility
Adults ages 18+ who are diagnosed with any form of endometrial cancer or pre-invasive endometrial cancer at any stage.
For more information about this study, please contact the study team at sarah.linhart@duke.edu.
Age Range
18-110
Sex/Genders
Female (cisgender)
Looking for Healthy Participants
Yes
What is Involved?
Description
If you choose to join this repository, we will collect medical information related to your cancer treatment for as long as you allow us to do so.
Locations
Duke University Hospital
Duke Raleigh Hospital
Visit Timing
Weekdays
Weekends
Evenings
Compensation
No
Spanish Materials Available
Yes
Study Details
Full Title
Endometrial Cancer Molecularly Targeted Therapy Consortium
Study Website
Principal Investigator
Angeles
Secord
Protocol Number
PRO00103465
Phase
N/A
Enrollment Status
Open to Enrollment